Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.
2.

Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Gregg JL, Brown KE, Mintz EM, Piontkivska H, Fraizer GC.

BMC Cancer. 2010 Apr 28;10:165. doi: 10.1186/1471-2407-10-165.

3.

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.

Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A.

Prostate. 2003 Jan 1;54(1):34-43.

PMID:
12481253
4.

Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.

Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G, Jung M, Polymeris ME, Diamandis EP.

Prostate. 2003 Sep 1;56(4):287-92.

PMID:
12858357
5.
6.

Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.

Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB.

Prostate. 2001 Sep 15;48(4):305-15.

PMID:
11536311
7.

Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer.

Halvorsen OJ, Rostad K, Øyan AM, Puntervoll H, Bø TH, Stordrange L, Olsen S, Haukaas SA, Hood L, Jonassen I, Kalland KH, Akslen LA.

Clin Cancer Res. 2007 Feb 1;13(3):892-7.

8.

Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.

Kinoshita M, Nakagawa T, Shimizu A, Katsuoka Y.

Int J Urol. 2005 Apr;12(4):390-7.

9.

Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.

Bi X, He H, Ye Y, Dai Q, Han Z, Liang Y, Zhong W.

Med Oncol. 2010 Mar;27(1):145-51. doi: 10.1007/s12032-009-9185-0. Epub 2009 Feb 26.

PMID:
19242826
10.

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

PLoS Med. 2006 Dec;3(12):e486.

11.

Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.

Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA, Stamey TA.

J Urol. 2003 Apr;169(4):1316-9.

PMID:
12629351
12.

Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.

Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB.

Cancer Res. 2001 Jun 15;61(12):4683-8.

13.

Microarray gene expression profiling and analysis in renal cell carcinoma.

Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A, DiDonato JA.

BMC Urol. 2004 Jun 22;4:9.

14.

Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.

Chetcuti A, Margan S, Mann S, Russell P, Handelsman D, Rogers J, Dong Q.

Prostate. 2001 May 1;47(2):132-40.

PMID:
11340636
15.

Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.

Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann C, Küster J, Schott W, Staehler G, Kretzler M, Hollstein M, Gröne HJ.

Am J Pathol. 2002 Jun;160(6):2169-80.

16.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
17.

The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.

Kuner R, Fälth M, Pressinotti NC, Brase JC, Puig SB, Metzger J, Gade S, Schäfer G, Bartsch G, Steiner E, Klocker H, Sültmann H.

J Mol Med (Berl). 2013 Feb;91(2):237-48. doi: 10.1007/s00109-012-0949-1. Epub 2012 Sep 4.

PMID:
22945237
18.

Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.

Jones AC, Trujillo KA, Phillips GK, Fleet TM, Murton JK, Severns V, Shah SK, Davis MS, Smith AY, Griffith JK, Fischer EG, Bisoffi M.

Prostate. 2012 Aug 1;72(11):1159-70. doi: 10.1002/pros.22465. Epub 2011 Nov 29.

19.

Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.

Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.

Urol Oncol. 2014 May;32(4):426-32. doi: 10.1016/j.urolonc.2013.09.006. Epub 2013 Dec 12.

PMID:
24332637
20.

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803.

PMID:
18668517

Supplemental Content

Support Center